Division of Nursing, Midwifery & Social Work, The University of Manchester, Manchester, UK
NIHR Applied Research Collaboration Greater Manchester, Manchester, UK.
BMJ Open. 2024 Jul 4;14(7):e083364. doi: 10.1136/bmjopen-2023-083364.
Reviews of commercial and publicly available smartphone (mobile) health applications (mHealth app reviews) are being undertaken and published. However, there is variation in the conduct and reporting of mHealth app reviews, with no existing reporting guidelines. Building on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we aim to develop the Consensus for APP Review Reporting Items (CAPPRRI) guidance, to support the conduct and reporting of mHealth app reviews. This scoping review of published mHealth app reviews will explore their alignment, deviation, and modification to the PRISMA 2020 items for systematic reviews and identify a list of possible items to include in CAPPRRI.
We are following the Joanna Briggs Institute approach and Arksey and O'Malley's five-step process. Patient and public contributors, mHealth app review, digital health research and evidence synthesis experts, healthcare professionals and a specialist librarian gave feedback on the methods. We will search SCOPUS, CINAHL Plus, AMED, EMBASE, Medline, APA PsycINFO and the ACM Digital Library for articles reporting mHealth app reviews and use a two-step screening process to identify eligible articles. Information on whether the authors have reported, or how they have modified the PRISMA 2020 items in their reporting, will be extracted. Data extraction will also include the article characteristics, protocol and registration information, review question frameworks used, information about the search and screening process, how apps have been evaluated and evidence of stakeholder engagement. This will be analysed using a content synthesis approach and presented using descriptive statistics and summaries. This protocol is registered on OSF (https://osf.io/5ahjx).
Ethical approval is not required. The findings will be disseminated through peer-reviewed journal publications (shared on our project website and on the EQUATOR Network website where the CAPPRRI guidance has been registered as under development), conference presentations and blog and social media posts in lay language.
正在进行并发表对商业和公开可用的智能手机（移动）健康应用程序（移动健康应用程序评论）的评论。然而，移动健康应用程序评论的进行和报告存在差异，目前没有报告指南。在系统评价和荟萃分析的首选报告项目（PRISMA）指南的基础上，我们旨在制定共识 APP 审查报告项目（CAPPRRI）指南，以支持移动健康应用程序评论的进行和报告。这项对已发表的移动健康应用程序评论的范围审查将探讨它们与 PRISMA 2020 系统评价项目的一致性、偏差和修改，并确定可能包含在 CAPPRRI 中的项目清单。
我们遵循乔安娜·布里格斯研究所的方法和阿克斯和奥马利的五步流程。患者和公众贡献者、移动健康应用程序评论者、数字健康研究和证据综合专家、医疗保健专业人员和专业图书馆员对方法提出了反馈。我们将在 SCOPUS、CINAHL Plus、AMED、EMBASE、Medline、APA PsycINFO 和 ACM 数字图书馆中搜索报告移动健康应用程序评论的文章，并使用两步筛选过程来确定合格的文章。将提取有关作者是否报告或他们如何在报告中修改 PRISMA 2020 项目的信息。数据提取还将包括文章特征、方案和注册信息、使用的审查问题框架、搜索和筛选过程信息、应用程序评估方法以及利益相关者参与的证据。这将使用内容综合方法进行分析，并使用描述性统计和摘要进行呈现。本方案已在 OSF（https://osf.io/5ahjx）上注册。
不需要伦理批准。研究结果将通过同行评审期刊出版物（在我们的项目网站和 EQUATOR 网络网站上共享，该网站已将 CAPPRRI 指南注册为正在开发中）、会议演示以及博客和社交媒体上的白话帖子进行传播。
